Clinical Trial Update: A Dose Ranging Study Of GW640385 Boosted With Ritonavir (Rtv) In Comparison To A RTV-Boosted Protease Inhibitor (PI) In HIV-1 Infected PI-Experienced Adults [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating GW640385 boosted with ritonavir versus a ritonavir-boosted protease inhibitor in HIV-1 infected, protease inhibitor-experienced adults;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• GW640385
• Ritonavir (Ritonavir)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus I, HIV-1 Infection | Phase 2 | Status: TERMINATED